Abnormal glucose tolerance in prepubertal patients with cystic fibrosis;Alteraciones hidrocarbonadas en pacientes impúberes con fibrosis quística

Anales de Pediatria

Volumn 77, Issue 5, 2012, Pages 339-343

  Martin Frias M ^a   Lamas Ferreiro, A ^a   Enes Romero, P ^a   Cano Gutierrez B ^a   Barrio Castellanos, R ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Abnormal glucose tolerance; Cystic fibrosis; Glycemic screening; Prepubertal

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BODY MASS; BRONCHOSPIROGRAPHY; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; LUNG FUNCTION; MALE; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PREPUBERTY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SPIROMETRY; STATISTICAL ANALYSIS;

CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84867687782     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2012.05.015     Document Type: Article

References (20)

1. P. Chamnan, B.S. Shine, C.S. Haworth, D. Bilton, and A.I. Adler Diabetes as a determinant of mortality in cystic fibrosis Diabetes Care 33 2010 311 316
2. A. Moran, D. Becker, S.J. Casella, P.A. Gottlieb, M.S. Kirkman, B.C. Marshall CFRD Consensus Conference Committee Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review Diabetes Care 33 2010 2677 2683
3. A. Moran, J. Dunitz, B. Nathan, A. Saeed, B. Holme, and W. Thomas Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality Diabetes Care 32 2009 1626 1631
4. S. Tofé, J.C. Moreno, M. Alonso, H. Escobar, and R. Barrio Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in Cystic Fibrosis Eur J Endocrinol 152 2005 1 8
5. A.E. Sterescu, B. Rhodes, R. Jackson, A. Dupuis, A. Hanna, and D.C. Wilson Natural history of glucose intolerance in patients with Cystic Fibrosis: ten-year prospective observation program J Pediatr 156 2010 613 617
6. R. Barrio, E. García, C. Gómez-Canadela, M. Gussinyé, J.F. Merino, and M.T. Muñoz Conferencia consenso: despistaje, diagnóstico y tratamiento de la diabetes relacionada con fibrosis quística An Pediatr 53 2002 573 579
7. A. Moran, C. Brunzell, R.C. Cohen, M. Katz, B.C. Marshall, G. Onady CFRD Guidelines Committee Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society Diabetes Care 33 2010 2697 2708
8. D.A. Elder, J.M. Wooldridge, L.M. Dolan, and D.A. Dáessio Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes J Pediatr 151 2007 653 658 (Pubitemid 350116132)
9. K.L. Ode, B. Frohnert, T. Laguna, J. Phillips, B. Holme, and W. Regelmann Oral glucose tolerance testing in children with cystic fibrosis Pediatr Diabetes 11 2010 487 492
10. D. Koch, M. Rainisio, U. Madessani, H.K. Harms, M.E. Hodson, and G. Mastella Presence of cystic fibrosis-related diabetes mellitus is tighly liked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis Pediatr Pulmonol 32 2001 343 350 (Pubitemid 33015650)
11. M.A. Rolon, K. Benali, A. Munck, J. Navarro, A. Clement, and N. Tubiana-Rufi CFRD: clinical impact of prediabetes and effects of insulina therapy Acta Paediatr 90 2001 860 867
12. J. Brodsky, S. Dougherty, R. Makani, R.C. Rubenstein, and A. Kelly Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis Diabetes Care 34 2011 292 295
13. S. Hameed, J.R. Morton, A. Jaffé, P.I. Field, Y. Belessis, and T. Yoong Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain Diabetes Care 33 2010 221 226
14. E. Bismuth, K. Laborde, P. Taupin, G. Velho, V. Ribault, and F. Jennane Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis J Pediatr 152 2008 540 545
15. K. Mohan, K.L. Israel, H. Miller, R. Grainger, M.J. Ledson, and M.J. Walshaw Long-term effect of insulin treatment in cystic fibrosis-related diabetes Respiration 76 2008 181 186
16. B.M. Nathan, T. Laguna, and A. Moran Recent trends in cystic fibrosis-related diabetes Curr Opin Endocrinolo Diabetes Obes 17 2010 335 341
17. C. Bizzarri, V. Lucidi, P. Ciampalini, S. Bella, B. Russo, and M. Cappa Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance J Endocrinol Invest 29 2006 RC1 RC4
18. S.M. O'Riordan, M.T. Dattani, and P.C. Hindmarsh Cystic fibrosis-related diabetes in childhood Horm Res Paediatr 73 2010 15 24
19. S. Buccini Graciela, and D.L. Wolfthal Valores de corte para índices de insulinorresistencia, insulinosensibilidad e insulinosecreción derivados de la fórmula HOMA y del programa HOMA2. Interpretación de los datos Rev Argent Endocrinol Metab 48 2008 3 21 (Pubitemid 351773920)
20. M. Martín-Frías, A. Lamas, E. Colino, M.A. Alvarez, R. Yelmo, and R. Barrio Continuous glucose monitoring system in the screening of glucose disorders in cystic fibrosis An Pediatr (Barc) 70 2009 120 125